WhiteOak Capital Pharma and Healthcare Fund-Reg (G) - Portfolio Analysis
- Equity
- Pharma & Healthcare
- Status: Open
Portfolio Overview
As of March 31, 2026
Asset Allocation
Equity: 98.05%Others: 1.95%
Market Cap
Large Cap: 19.23%Small Cap: 40.42%Mid Cap: 28.27%Others: 10.13%
Number of stocks
55
Top 10 Holdings
54.47% of portfolio
Market Cap of Equity
Large Cap
19.23%
Small Cap
40.42%
Mid Cap
28.27%
Others
10.13%
Companies Allocation of Equity
Sun Pharmaceuticals Industries Ltd12.35%
J.B. Chemicals & Pharmaceuticals Ltd8.90%
Lupin Ltd5.77%
Divi's Laboratories Ltd5.31%
Apollo Hospitals Enterprise Ltd4.24%
Laurus Labs Ltd3.93%
Fortis Healthcare Ltd3.85%
Max Healthcare Institute Ltd Ordinary Shares3.79%
Glenmark Pharmaceuticals Ltd3.17%
Krishna Institute of Medical Sciences Ltd3.16%
Sector Allocation of Equity
Healthcare86.27%
Basic Materials7.20%
Equity4.58%
SIP Amount
Monthly SIP Date
WhiteOak Capital Pharma and Healthcare Fund-Reg (G)


Is This Mutual Fund Right for You?
+10k investors used our Suitability Test to get better returns
Fund Suitability Test
Let's Get Started.
Frequently Asked Questions
Everything You Need To Know To Get Started With Confidence
In mutual funds, "market cap allocation" means how assets of the fund are divided among various market capitalizations, which are based on the total market value of the outstanding shares of stock of a company. Market capitalization falls into three major categories: Large-cap, Mid-cap, Small-cap funds.